精氨酸酶2通过调节亚硝化应激介导肾脏缺血再灌注损伤
该研究在HK-2细胞和小鼠缺血再灌注模型中探讨精氨酸酶2(ARG2)的作用。ARG2在肾皮质小管表达并于损伤后升高;敲低ARG2可降低活性氧和3-硝基酪氨酸水平。Arg2敲除小鼠肾功能异常和急性肾小管坏死评分显著减轻,3-硝基酪氨酸积累和肾小管细胞凋亡减少;精氨酸酶抑制剂Nω-羟基-去甲-L-精氨酸可模拟该保护效应。结论:ARG2通过亚硝化应激在缺血再灌注性AKI中起关键作用,ARG2特异性抑制剂可能有效治疗肾脏缺血再灌注损伤。
要点
- ARG2在肾皮质小管表达,缺血再灌注后表达升高。
- 敲低或敲除ARG2可减轻亚硝化应激、肾小管坏死和凋亡。
- 精氨酸酶抑制剂可减轻小鼠肾脏缺血再灌注损伤。
核心结论
- ARG2通过亚硝化应激在肾脏缺血再灌注诱导的急性肾损伤中发挥关键介导作用。
- ARG2特异性抑制剂可能成为治疗肾脏缺血再灌注损伤的有效策略。
研究设计与样本
- 研究使用人近端小管细胞(HK-2)和小鼠肾脏缺血再灌注损伤模型。
- 在HK-2细胞中采用缺氧-复氧损伤,并比较ARG2敲低与对照siRNA。
- 使用Arg2敲除小鼠与野生型小鼠比较缺血再灌注损伤后的结局。
- 使用精氨酸酶抑制剂Nω-羟基-去甲-L-精氨酸处理小鼠。
主要发现
- ARG2主要表达于肾皮质小管,缺血再灌注损伤后表达增加。
- HK-2细胞中ARG2在胞质呈点状表达,缺氧-复氧后上调。
- 与对照siRNA相比,ARG2敲低降低缺氧-复氧损伤后活性氧和3-硝基酪氨酸水平。
- Arg2敲除小鼠缺血再灌注诱导的肾功能异常和急性肾小管坏死评分显著减轻,且无明显血压变化。
- Arg2敲除小鼠较野生型小鼠3-硝基酪氨酸积累和肾小管细胞凋亡减轻。
临床怎么用
- 临床可关注ARG2作为缺血再灌注性AKI的潜在治疗靶点。
- ARG2特异性抑制剂可能用于预防或治疗肾脏缺血再灌注损伤,但尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney ischemia-reperfusion injury is a major cause of acute kidney injury (AKI). Following reduced kidney perfusion, the pathological overproduction of reactive oxygen and reactive nitrogen species play a substantial role in the development of kidney ischemia-reperfusion injury. Arginase 2 (ARG2) competes with nitric oxide synthase for the same substrate, L-arginine, and is implicated in the regulation of reactive nitrogen species. Therefore, we investigated the role of ARG2 in kidney ischemia-reperfusion injury using human proximal tubule cells (HK-2) and a mouse model of kidney ischemia-reperfusion injury. ARG2 was predominantly expressed in kidney tubules of the cortex, which was increased after ischemia-reperfusion injury. In HK-2 cells, ARG2 was expressed in punctate form in the cytoplasm and upregulated after hypoxia-reoxygenation. ARG2 knockdown reduced the level of reactive oxygen species and 3-nitrotyrosine after hypoxia-reoxygenation injury compared with control siRNA. Consistent with these results, in Arg2 knockout mice, abnormal kidney function and the increased acute tubular necrosis score induced by ischemia-reperfusion injury was significantly reduced without any obvious blood pressure changes. Additionally, an accumulation of 3-nitrotyrosine and apoptosis of renal tubule cells were attenuated in Arg2 knockout mice compared with wild-type mice. Inhibition of arginase by Nω-hydroxy-nor-L-arginine alleviated kidney ischemia-reperfusion injury like the results found in Arg2 knockout mice. Thus, ARG2 plays a pivotal role in ischemia-reperfusion-induced AKI by means of nitrosative stress. Hence, an ARG2-specific inhibitor may effectively treat kidney ischemia-reperfusion injury.
引用
- Hara M, Torisu K, Tomita K, et al. Arginase 2 is a mediator of ischemia-reperfusion injury in the kidney through regulation of nitrosative stress. Kidney Int. 2020. PMID: 32739205. doi:10.1016/j.kint.2020.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。